System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Mats Remberger is an expert in Transplantation at Uppsala University Hospital (Sweden). As of July 2026, ScienceLeadR ranks Mats Remberger in the top 1% of experts worldwide for Stem Cell Transplantation, Graft vs Host Disease and Cell Transplantation. Mats Remberger has authored 382 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 1,022 (community average: 125). How the SLR is computed.

LeadR Profile

Mats Remberger Uppsala University Hospital Sweden
1 022 ScienceLeadR Reputation 1022

Unlock

Register Login
Network Map

Transplantation

Subspecialties: Hematology - Surgery - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1994 - 2026
Source: PubMed

Uppsala University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 382

Citations

Citations: 18 269 1st author: 50 Last author: 44 Unique author: 1

Main journals

Bone Marrow Transplant 61
Biol Blood Marrow Transplant 50
Blood 35
Transplantation 24
Transplant Cell Ther 21

Best Journals

Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Ferritin as a Pre-Transplant Biomarker for Post-Transplant Outcomes in Allogeneic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide.
PMID 41839367 — cells, microscopy, electron, scanning transmission, incidence, hematopoietic stem cell transplantation, cyclophosphamide, stem cells, biomarkers, ferritins, graft vs host disease, transplants, cell transplantation, stem cell transplantation, transplantation		Transplant Cell Ther20260
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis.
PMID 42132052 — cells, mortality, microscopy, electron, scanning transmission, lymphoma, neoplasms, leukemia, stem cells, transplants, cell transplantation, stem cell transplantation, transplantation		Leuk Lymphoma20260
Early initiation of defibrotide is associated with better survival in sinusoidal obstruction syndrome/veno-occlusive disease in adults: experience from two Canadian centers.
PMID 42049137 — mortality, hepatic veno-occlusive disease, hematopoietic stem cell transplantation, diagnosis, transplants		Transplant Cell Ther20260
Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical Utility.
PMID 41992574 — cells, lung, neoplasms, biopsy, mycoses, cell transplantation, transplantation		Transpl Infect Dis20260
The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes.
PMID 41595214 — cells, comorbidity, lung, incidence, smokers, graft vs host disease, transplants, history, smoking, bronchiolitis obliterans syndrome		Cancers (Basel)20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Director: 1

By phase:

Phase 1/Phase 2 2
Phase 2 1
Phase 3 1

By status:

Completed 2
Terminated 1
Unknown 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS